v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 57,659 $ 48,668
General and administrative 17,038 19,223
Total operating expenses 74,697 67,891
Loss from operations (74,697) (67,891)
Interest and other income, net 1,188 1,634
Net loss (73,509) (66,257)
Other comprehensive (loss) gain:    
Unrealized (loss) gain on available-for-sale securities (16) 378
Comprehensive loss $ (73,525) $ (65,879)
Net loss per common share:    
Basic and diluted net loss per common share $ (1.20) $ (1.44)
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share 61,208 46,124

Source